CN101686999A - 一种生产防止传染病的药剂的方法 - Google Patents
一种生产防止传染病的药剂的方法 Download PDFInfo
- Publication number
- CN101686999A CN101686999A CN200780049262A CN200780049262A CN101686999A CN 101686999 A CN101686999 A CN 101686999A CN 200780049262 A CN200780049262 A CN 200780049262A CN 200780049262 A CN200780049262 A CN 200780049262A CN 101686999 A CN101686999 A CN 101686999A
- Authority
- CN
- China
- Prior art keywords
- solution
- extract
- infectious diseases
- medicament
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 10
- 208000035473 Communicable disease Diseases 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 4
- 239000000284 extract Substances 0.000 claims abstract description 25
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 14
- 239000001301 oxygen Substances 0.000 claims abstract description 14
- 241001115402 Ebolavirus Species 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 15
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 14
- 241000218206 Ranunculus Species 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000000346 sugar Nutrition 0.000 claims description 6
- 241000192700 Cyanobacteria Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 4
- 241001327634 Agaricus blazei Species 0.000 claims description 3
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 3
- 210000000416 exudates and transudate Anatomy 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 244000018436 Coriandrum sativum Species 0.000 claims description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 claims description 2
- 244000141009 Hypericum perforatum Species 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 244000151637 Sambucus canadensis Species 0.000 claims description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 claims description 2
- 235000007123 blue elder Nutrition 0.000 claims description 2
- 235000007124 elderberry Nutrition 0.000 claims description 2
- 235000008995 european elder Nutrition 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- LWNCNSOPVUCKJL-UHFFFAOYSA-N [Mg].[P] Chemical compound [Mg].[P] LWNCNSOPVUCKJL-UHFFFAOYSA-N 0.000 claims 9
- 241000546188 Hypericum Species 0.000 claims 1
- 240000009164 Petroselinum crispum Species 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 235000011197 perejil Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 241000233866 Fungi Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 239000004030 hiv protease inhibitor Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002664 inhalation therapy Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006052504.3 | 2006-11-06 | ||
| DE102006052504A DE102006052504A1 (de) | 2006-11-06 | 2006-11-06 | Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit |
| PCT/EP2007/009490 WO2008055620A2 (de) | 2006-11-06 | 2007-10-31 | Verfahren zum herstellen eines mittels gegen eine infektionskrankheit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101686999A true CN101686999A (zh) | 2010-03-31 |
Family
ID=39114577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200780049262A Pending CN101686999A (zh) | 2006-11-06 | 2007-10-31 | 一种生产防止传染病的药剂的方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100021556A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2089043A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2010508367A (cg-RX-API-DMAC10.html) |
| CN (1) | CN101686999A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2668741A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE102006052504A1 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2009118361A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2008055620A2 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA200903936B (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551535B1 (en) | 2012-08-06 | 2013-10-08 | Sarah McCann | Homeopathic remedies and methods for enhancing weight loss |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3936355A (en) * | 1973-11-12 | 1976-02-03 | The Regents Of The University Of California | Microorganism growth media and the stabilization thereof |
| GB2135668B (en) * | 1982-12-25 | 1986-08-13 | Takara Shuzo Co | Of4949, a physiologically active substance and derivatives thereof |
| US5456924A (en) | 1988-12-23 | 1995-10-10 | Immunotec Research Corporation Ltd. | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| GB9807781D0 (en) | 1998-04-09 | 1998-06-10 | Univ Bristol | Therapeutic agent |
| US6143780A (en) * | 1999-09-17 | 2000-11-07 | Uniroyal Chemical Company, Inc. | N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV |
| JP2002218969A (ja) * | 2001-01-26 | 2002-08-06 | Tsukuba Bio Syst:Kk | 食用菌の製造方法 |
| ITMI20011633A1 (it) * | 2001-07-27 | 2003-01-27 | San Raffaele Centro Fond | Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv |
-
2006
- 2006-11-06 DE DE102006052504A patent/DE102006052504A1/de not_active Withdrawn
-
2007
- 2007-10-31 ZA ZA200903936A patent/ZA200903936B/xx unknown
- 2007-10-31 RU RU2009118361/15A patent/RU2009118361A/ru unknown
- 2007-10-31 WO PCT/EP2007/009490 patent/WO2008055620A2/de not_active Ceased
- 2007-10-31 EP EP07819519A patent/EP2089043A2/de not_active Ceased
- 2007-10-31 CN CN200780049262A patent/CN101686999A/zh active Pending
- 2007-10-31 CA CA002668741A patent/CA2668741A1/en not_active Abandoned
- 2007-10-31 JP JP2009535608A patent/JP2010508367A/ja active Pending
- 2007-10-31 US US12/513,674 patent/US20100021556A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2089043A2 (de) | 2009-08-19 |
| US20100021556A1 (en) | 2010-01-28 |
| JP2010508367A (ja) | 2010-03-18 |
| RU2009118361A (ru) | 2010-12-20 |
| CA2668741A1 (en) | 2008-05-15 |
| WO2008055620A3 (de) | 2009-03-05 |
| ZA200903936B (en) | 2010-08-25 |
| WO2008055620A2 (de) | 2008-05-15 |
| DE102006052504A1 (de) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2548880A3 (en) | Compositions for increasing telomerase activity | |
| CN103652846A (zh) | 一种北虫草含片的生产方法 | |
| CN102440386A (zh) | 一种全复合人体抗氧化剂 | |
| WO2010019016A3 (ko) | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물 | |
| US8658181B2 (en) | Pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease | |
| Wang et al. | Renoprotective effects of shout camphor Medicinal Mushroom (Taiwanofungus camphorates, Basidiomycetes) Mycelia on several media in mice with chronic kidney disease | |
| CN111568921A (zh) | 一种促进冠状病毒患者康复的新型硒制剂配方及其制备方法 | |
| TWI637748B (zh) | 蓮蓬萃取物用於治療及／或預防腎臟病變之用途 | |
| CN105232588B (zh) | 一种具有保护酒精性肝损伤作用的保健食品及制备方法 | |
| CN105497577A (zh) | 一种治疗高血压的中药组合物 | |
| US20100021556A1 (en) | Method for the Production of an Agent Against an Infectious Disease | |
| CN105106251B (zh) | 一种破壁灵芝孢子粉胶囊的制备方法 | |
| CN102151294A (zh) | 养心虫草酒 | |
| CN104856925A (zh) | 一种富含牛樟芝提取物的去痘精华 | |
| Korro et al. | PRIMARY DATA ON REDUCTION OF CONSEQUENCES OF COVID-19 THROUGH THE USE OF PROPOLIS IN ALBANIAN PATIENTS | |
| Latifipour et al. | Cardiodepressant effects of ethanol extract of pomegranate (Punica granatum) skin on rat isolated heart. | |
| CN107184690B (zh) | 具有抗炎作用的鸡矢藤-葫芦茶组合物及其制备方法和应用 | |
| WO2018093735A2 (en) | Method for treating hepatitis c | |
| US20080153913A1 (en) | Nutritional Supplement and Protocol | |
| JP2006342073A (ja) | 免疫活性増強成分、並びにそれを含む飲食物類及び医薬部外品類 | |
| CN106309457B (zh) | 一种熊果酸-阿司匹林偶联物在制备保肝护肝药物中的应用 | |
| CN106511530A (zh) | 一种木瓜干细胞胶囊 | |
| CN104857469A (zh) | 一种用于治疗风湿性关节炎的外用中药膏 | |
| WO2021224790A1 (en) | Vsv (vitamin c-spirulina-vitamin d) composition, kit and method | |
| CN102920832A (zh) | 一种用于预防和治疗由外伤引起创伤的消毒膏剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100331 |